Tatva Chintan Pharma IPO Details

Tatva Chintan Pharma Chem IPOTatva Chintan Pharma Chem IPO description – Tatva Chintan Pharma Chem is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). The company is the largest and only commercial manufacturer of SDAs for zeolites in India while also enjoying the second largest position globally. In addition, the company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe.

The company’s products – 138 as of 31 December 2020 – are used across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from serving the domestic market, the company exports its products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. During the nine months ended 31 December 2020, exports of products accounted for 70.7% of its revenue from operations.

Promoters of Tatva Chintan Pharma – Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Shekhar Rasiklal Somani
Tatva Chintan Pharma Chem IPO details
Subscription Dates 16 – 20 July 2021
Price Band INR1,073 – 1,083 per share
Fresh issue INR225 crore
Offer For Sale INR275 crore
Total IPO size INR500 crore
Minimum bid (lot size) 13 shares
Face Value  INR10 per share
Retail Allocation 35%
Listing On NSE, BSE

Tatva Chintan Pharma's financial Performance (in INR crore)

  FY2018 FY2019 FY2020 FY2021
Revenue 137.3 206.8 264.6 306.3
Expenses 118.3 180.2 217.0 245.6
Comprehensive income 12.3 20.5 37.6 52.4
Margin (%) 9.0 9.9 14.2 17.1

More about Tatva Chintan Pharma Chem IPO

Registrar of Tatva Chintan Pharma IPO

Link Intime India Private Limited C-101, 1st Floor,
247 Park Lal Bahadur Shastri Marg,
Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website: http://www.linkintime.co.in

Tatva Chintan Pharma Contact Details

Tatva Chintan Pharma Chem Limited
Plot No. 353, Makarpura GIDC,
Vadodara, Gujarat – 390 010
Phone: +91 75748 48533
Email: [email protected]
Website: www.tatvachintan.com

Valuation of Tatva Chintan Pharma (as of FY2021)

Earnings Per Share (EPS): INR26.02
Price/Earnings (PE ratio): 41.24 – 41.62
Return on Net Worth (RONW): 31.49%
Net Asset Value (NAV): INR82.62 per share

Tatva Chintan Pharma IPO GMP Daily Trend

Date Tatva Chintan IPO GMP Kostak Subject to Sauda
28 July 2021 INR1,150
27 July 2021 INR1,100
26 July 2021 INR1,000 INR450 INR8,800
23 July 2021 INR900 INR450 INR7,800
22 July 2021 INR800 INR450 INR7,300
21 July 2021 INR800 INR450 INR7,300
20 July 2021 INR700 INR400 INR6,800
19 July 2021 INR700 INR400 INR6,800
17 July 2021 INR640 INR350 INR6,100
16 July 2021 INR620 INR350 INR5,700
15 July 2021 INR600 INR350 INR5,300
14 July 2021 INR560 INR340 INR5,000
13 July 2021 INR500 INR300 INR5,000
12 July 2021 INR450 INR300 INR5,000

Tatva Chintan Pharma IPO Subscription Details

Category Shares offered Subscription (no. of times, at 5 PM)
Day 1 Day 2 Day 3
QIB 9,31,966 0.51 1.97 185.23
NII 6,98,975 1.13 12.21 512.22
Retail 16,30,941 8.25 23.75 35.35
         
Total 32,61,882 4.51 15.05 180.36

Tatva Chintan Pharma IPO Review - Broker Views

Angel Broking – Subscribe
BP Wealth – Subscribe
Choice Broking – Subscribe
Elite Wealth – Subscribe
Hem Securities – Subscribe
ICICIdirect – Unrated
Investmentz – Subscribe for long term
KR Choksey – Subscribe
Marwadi Financial Services – Subscribe
Mehta Equities – Subscribe
Motilal Oswal – Subscribe
Reliance Securities – Subscribe
Samco Securities – Subscribe with caution
SMC Global Securities – 2.5/5
Ventura Securities – Subscribe

Tatva Chintan Pharma IPO Allotment Status

Tatva Chintan Pharma IPO allotment status isn’t yet available on Link Intime’s website. Once available, click on this link to get allotment status.

Meanwhile, bank debits have started. Check bank statement for removed lien or amount deduction to know allotment status.  

Listing Performance of Tatva Chintan Pharma Chem

IPO Opening Date: 16 July 2021
IPO Closing Date: 20 July 2021
Finalisation of Basis of Allotment: 26 July 2021
Initiation of refunds: 27 July 2021
Transfer of shares to demat accounts: 28 July 2021
Listing Date: 29 July 2021
Opening Price on NSE: INR2,111.85 per share (up 95% from IPO price)
Closing Price on NSE: INR2,312.2 per share (up 113.5% from IPO price)

6 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Brokerage-free IPO Investing

X